Skip to main content

A Review on: Analysis of The First Oral, Direct Factor Xa Inhibitor; Rivaroxaban

Research Authors
Noha M. Hosny
Research Journal
Microchemical Journal
Research Publisher
Elsevier
Research Rank
1
Research Vol
159
Research Website
https://www.sciencedirect.com/science/article/abs/pii/S0026265X20321184
Research Year
2020
Research Member
Research Abstract

The presented review with 74 references covers most of the methods described for the analysis of Rivaroxaban (RXB); the first and selective oral direct inhibitor of activated factor X in its pure forms, in different pharmaceutical dosage forms and in biological fluids. The review covers the period from 2005 till now.